GGrantIndex
Sort

30,917 grants matching “tumor microenvironment”

Center on the Microenvironment and Metastasis

$2,572,097
Michael L Shuler · Cornell University · U54 · FY2010 · CA

Precision Medicine of Cancer

$2,570,099
Curtis Harris · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA

Targeted Therapies in Melanoma

$2,567,345
Meenhard Herlyn · Wistar Institute · P01 · FY2013 · CA

Cancer Center Support Grant

$2,562,428
Gerold Bepler · Wayne State University · P30 · FY2019 · CA

Cancer Center Support Grant

$2,562,428
Gerold Bepler · Wayne State University · P30 · FY2017 · CA

Cancer Center Support Grant

$2,562,428
Gerold Bepler · Wayne State University · P30 · FY2020 · CA

Cancer Center Support Grant

$2,562,428
Gerold Bepler · Wayne State University · P30 · FY2018 · CA

Epigenetic basis and therapeutic targeting of the unique lymphoma immunological niche

$2,561,215
Leandro C Cerchietti · Weill Medical Coll Of Cornell Univ · P01 · FY2024 · CA

Lymphoma Outcomes SPORE

$2,561,113
Christopher R Flowers · University Of Tx Md Anderson Can Ctr · U54 · FY2025 · CA

Center for pediatric tumor cell atlas

$2,560,774
Kai Tan · Children'S Hosp Of Philadelphia · U2C · FY2018 · CA

Cancer Center Support Grant

$2,551,335
Gerold Bepler · Wayne State University · P30 · FY2016 · CA

Discovering and Exploiting Mechanisms of Neuroblastoma Therapy Resistance

$2,545,516
John M Maris · Children'S Hosp Of Philadelphia · P01 · FY2024 · CA

Precision Medicine of Cancer

$2,545,004
Curtis Harris · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA

Dissecting tumor metabolic heterogeneity in vivo

$2,542,500
Kivanc Birsoy · Rockefeller University · DP2 · FY2017 · CA

THERAPEUTIC TARGETING OF THE TUMOR MICROENVIRONMENT IN TRIPLE-NEGATIVE BREAST CANCER PATIENTS AT HIGH RISK OF RELAPSE AND PRECLINICAL MODELS OF LUNG METASTASES

$2,542,500
Weill Medical College Of Cornell University · · FY2025 · Defense Health Agency

Experimental Therapy for Brain Tumors

$2,542,342
John H Sampson · Duke University · P01 · FY2021 · CA

Targeted Therapies in Melanoma

$2,538,781
Meenhard Herlyn · Wistar Institute · P01 · FY2019 · CA

Experimental Therapy for Brain Tumors

$2,536,844
John H Sampson · Duke University · P01 · FY2020 · CA

Tumor organoids and cell polarity: models and mechanisms for cancer research

$2,533,692
Senthil Muthuswamy · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA

Transforming Human Pancreatic Cancer Into An Immunologic Disease

$2,530,690
Elizabeth Marion Jaffee · Johns Hopkins University · P01 · FY2023 · CA

Transforming Human Pancreatic Cancer Into An Immunologic Disease

$2,530,688
Elizabeth Marion Jaffee · Johns Hopkins University · P01 · FY2022 · CA

The Center for Tumor-Immune Systems Biology at MSKCC

$2,522,250
Christina S Leslie · Sloan-Kettering Inst Can Research · U54 · FY2024 · CA

Interplay of tumor genomic and immune characteristics and external drivers of health to improve cancer health outcomes

$2,520,895
Susan M Chang · University Of California, San Francisco · U54 · FY2025 · CA

Dissection of in situ myeloid signaling using image-guided synthetic control

$2,520,000
Miles A Miller · Massachusetts General Hospital · DP2 · FY2020 · CA

Tumor microenvironment in CLL and MCL: pathogenesis, targets, and therapy

$2,519,818
Adrian U Wiestner · National Heart, Lung, And Blood Institute · ZIA · FY2023 · HL